Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Papillary Adenocarcinoma”

302 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 302 results

Not applicableUnknownNCT04411290
What this trial is testing

Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases

Who this might be right for
Thyroid CarcinomaThyroid Papillary CarcinomaMultinodular Goiter, Adolescent+8 more
Umraniye Education and Research Hospital 200
Testing effectiveness (Phase 2)Study completedNCT03685448
What this trial is testing

ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB)

Who this might be right for
Renal Cell CarcinomaPapillary Renal Cell Carcinoma Type 1Papillary Renal Cell Carcinoma Type 2+3 more
Australian and New Zealand Urogenital and Prostate Cancer Trials Group 35
Not applicableLooking for participantsNCT07024680
What this trial is testing

Real World Study of Effectiveness of Sunitinib or Sorafenib to Chinese Unresectable Locally Advanced or Metastatic PRCC

Who this might be right for
Papillary Renal Cell Carcinoma
AstraZeneca 150
Testing effectiveness (Phase 2)Study completedNCT02761057
What this trial is testing

Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed

Who this might be right for
Locally Advanced Papillary Renal Cell CarcinomaMetastatic Papillary Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v7+4 more
National Cancer Institute (NCI) 152
Testing effectiveness (Phase 2)Study completedNCT00126503
What this trial is testing

Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Chromophobe Renal Cell CarcinomaClear Cell Renal Cell CarcinomaPapillary Renal Cell Carcinoma+3 more
National Cancer Institute (NCI) 73
Not applicableLooking for participantsNCT07376837
What this trial is testing

Radiofrequency Ablation for Curative Treatment of Small Low-Risk Papillary Thyroid Cancer: Pilot Study

Who this might be right for
Thyroid Papillary Carcinoma
University Health Network, Toronto 30
Not applicableActive Not RecruitingNCT04624477
What this trial is testing

Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer

Who this might be right for
Papillary Thyroid CancerPapillary Thyroid CarcinomaPapillary Microcarcinoma of the Thyroid
University Health Network, Toronto 450
Testing effectiveness (Phase 2)Study completedNCT00335556
What this trial is testing

Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors

Who this might be right for
Childhood Renal Cell CarcinomaClear Cell Renal Cell CarcinomaClear Cell Sarcoma of the Kidney+10 more
Children's Oncology Group 291
Not applicableUnknownNCT06241092
What this trial is testing

AI-Based Multimodal Multi-tasks Analysis Reveals Tumor Molecular Heterogeneity, Predicts Preoperative Lymph Node Metastasis and Prognosis in Papillary Thyroid Carcinoma

Who this might be right for
Papillary Thyroid Carcinoma; Molecular Heterogeneity; Multi-model Analysis; Artificial Intelligence; Lymph Node Metastases; Disease-free Survival
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 256
Testing effectiveness (Phase 2)Active Not RecruitingNCT03157128
What this trial is testing

Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)

Who this might be right for
Non-Small Cell Lung CancerMedullary Thyroid CancerColon Cancer+1 more
Eli Lilly and Company 857
Testing effectiveness (Phase 2)Study completedNCT00025467
What this trial is testing

Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer

Who this might be right for
Endometrial AdenoacanthomaEndometrial AdenocarcinomaEndometrial Adenosquamous Cell Carcinoma+3 more
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT00121628
What this trial is testing

A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer

Who this might be right for
Thyroid Cancer
Amgen 184
Large-scale testing (Phase 3)Study completedNCT00002493
What this trial is testing

Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer

Who this might be right for
Endometrial CancerPsychosocial Effects of Cancer and Its Treatment
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Study completedNCT04731467
What this trial is testing

CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors

Who this might be right for
Solid TumorNon Small Cell Lung CancerPancreatic Cancer+4 more
Famewave Ltd. 79
Testing effectiveness (Phase 2)Active Not RecruitingNCT01709292
What this trial is testing

Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer

Who this might be right for
Thyroid Cancer
M.D. Anderson Cancer Center 24
Early research (Phase 1)Study completedNCT00470496
What this trial is testing

Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer

Who this might be right for
Recurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the LipRecurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity+52 more
Roswell Park Cancer Institute 15
Testing effectiveness (Phase 2)Study completedNCT00729157
What this trial is testing

Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy

Who this might be right for
Recurrent Thyroid Gland CarcinomaStage III Thyroid Gland Follicular CarcinomaStage III Thyroid Gland Papillary Carcinoma+2 more
National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Study completedNCT02393690
What this trial is testing

Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer

Who this might be right for
Metastatic Thyroid Gland CarcinomaPoorly Differentiated Thyroid Gland CarcinomaRecurrent Thyroid Gland Carcinoma+8 more
Academic and Community Cancer Research United 60
Testing effectiveness (Phase 2)Study completedNCT00515073
What this trial is testing

Papillary Serous Carcinoma of the Endometrium

Who this might be right for
Endometrial Cancer
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT05150691
What this trial is testing

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

Who this might be right for
HER2-positive Advanced Solid Tumor
DualityBio Inc. 796
Load More Results